By Samuel Sutton, Senior Analyst True to our deep tech and impact objectives, in February 2023, Matū announced our lead investment into cleantech carbon capture through Captivate Technology. Captivate is…
Our 16th portfolio company, Opo Bio, has launched out of stealth mode today with an article in the New Zealand Herald. Developing cultivated meat ingredients for the world, former Matū analyst…
We had a good showing at the Kiwinet Research Commercialisation Awards last Thursday, with six Matū team members cheering on our finalist portfolio companies. Prof. Justin Hodgkiss (Executive Director at…
We join our portfolio company Mekonos in congratulating Professor Carolyn Bertozzi, who was awarded the Nobel Prize in Chemistry last week for her work in click chemistry with bioorthogonal reactions.…
Our portfolio company #1 Mekonos has announced an exciting partnership to build designer chromosomes as part of the next generation of cell therapy. These therapies are the key to personalised…
The Auckland Bioengineering Institute at the University of Auckland has received a $15mil grant to develop build towards a complete digital model of the human body, in particular the various…
Our Iraoho-Analyst Olivia Ogilvie has a look at one of the rising trends in scientific innovation and commercialisation. Cellular agriculture (cell-ag) is an alternative biotechnology-based production method for agriculture products…